Overall, subgroup 2 and subgroup 3 (to a lesser extent) were associated with poor survival in MYCN non-amplified neuroblastomas, suggesting fundamentally different mechanisms leading to an advanced disease. This evidence concerns the gene MYCN and neuroblastoma.